The global primary cells market is expected to witness a significant growth over the forecast period. Primary cells are cells extracted from living organisms and maintained in culture for a short period of time. They are considered a valuable tool for cell research as they are not subject to genetic modifications and can be used to study the normal cellular environment or the effect of various drugs on the cells.
According to the new market research report "Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025", published by MarketsandMarkets™, the market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7%
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
Primary cells are cells that are obtained directly from an organism and can be kept alive in a laboratory setting for a limited period of time, usually days to weeks. They are not immortal and can only be passaged a limited number of times before they can no longer be maintained. Primary cells are useful for research applications such as drug discovery, toxicology, and cell biology. They are also used in clinical applications such as tissue engineering and regenerative medicine.
The rising demand for primary cells in pharmaceutical and biotechnology research is driving the growth of the primary cells market. The development of new techniques such as stem cell-based therapy and regenerative medicine has resulted in increased investments in research and development, which is further contributing to the growth of the market. Moreover, factors such as increasing focus on personalized medicine and biobanking, growing investments in cell-based research, and the rising demand for animal-derived primary cells are driving the growth of the market.
On the basis of product type, the primary cells market has been segmented into mammalian cells, plant cells, insect cells, and other cells. The mammalian cells segment is expected to dominate the market due to the increasing use of these cells in disease diagnosis and drug development processes. In addition, the availability of a wide range of mammalian cell lines, such as human embryonic kidney cells, HeLa cells, and CHO cells, along with their versatile nature, is driving the growth of this segment.
Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960
On the basis of application, the primary cells market has been segmented into research, drug discovery, and clinical applications. The research application segment is expected to dominate the market due to the increasing use of primary cells in various scientific studies such as cancer biology, cell biology, and immunology.
Key Market Players
The key players operating in the primary cells market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl (Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and Biopredic International (France)
The market players are focused on entering into strategic collaborations and agreements with academic institutes and research organizations to strengthen their presence in the global primary cells market. For instance, in April 2019, STEMCELL Technologies Inc. entered into a strategic collaboration with Leiden University Medical Center to develop technologies for the generation of human induced pluripotent stem cells (iPSCs).
Some Key Questions answered in this Report are
- What are the current market trends and dynamics in the Primary Cells market and valuable opportunities for emerging players?
- What is driving Primary Cells market?
- What are the key challenges to market growth?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which product type segment holds a larger market share and why?
- Are low and middle-income economies investing in the Primary Cells market?
- Key growth pockets on the basis of regions, types, applications, and end-users
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East Africa?
Unique data points of this report
- Statistics on Primary Cells and spending worldwide
- Recent trends across different regions in terms of adoption of Primary Cells across industries
- Notable developments going on in the industry
- Attractive investment proposition for segments as well as geography
- Comparative scenario for all the segments for years 2021 (actual) and 2027 (forecast)
Get Special Pricing on Bundle Reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=32854960
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
